Tag: diabetic foot ulcer
Decades of data show hyperbaric oxygen therapy belongs in the diabetic...
“Diabetic foot ulcers are very difficult to treat, and the approach should be multi-factorial,” Andrew Applewhite tells iWounds News. “If you do not offload...
Previously described patient-centred clinical success measure after revascularisation for diabetic foot...
Patient-centred clinical success after lower-extremity revascularisation for people with diabetic foot wounds was achieved among 63% of patients in a new analysis—but researchers suggest...
HIFLO RCT finds increased wound closure and high quality of healing...
Treatment with the mVASC microvascular tissue graft product (MicroVascular Tissues) results in superior wound closure compared to standard of care alone, the first randomised...
Diabetic amputations soared amid Italian pandemic lockdown
Patients with diabetic foot ulceration (DFUs) in Italy had more amputations during the height of the coronavirus pandemic—March to May 2020—than over the same...
PolarityTE announces positive top-line data from interim analysis of SkinTE diabetic...
PolarityTE have announced positive results from a protocol-specified interim analysis of the first 50 patients enrolled in a multicentre randomised controlled trial evaluating treatment...
New reimbursement coding and US$22.6M equity financing for Reapplix
Reapplix has received Medicare reimbursement coding instructions from the Centers for Medicare and Medicaid Services (CMS) with a national average payment rate of US$1,622.74....
MTF Biologics wound care tissue forms now accessible to over 240...
MTF Biologics has announced that new positive coverage decisions by Aetna, Centene Corporation, WellCare and Tufts Health Plan will provide greater access to its...
Aurealis Therapeutics reveals first use of biologic drug AUP-16 for chronic...
Aurealis Therapeutics has announced that the first diabetic foot ulcer (DFU) patient has been dosed with AUP-16, its three-in-one combination biologic drug for chronic...
Recurrent ulcers “occur in anatomically-distinct locations” for patients in diabetic foot...
Diabetic foot ulcers frequently occur in different locations to previously-healed wounds for patients in diabetic foot remission, according to a secondary analysis of trial...
Trial results show three-fold reduction in diabetic foot ulcer size with...
Microbion Corporation has announced results from a Phase 1b trial of its microbial bioenergetic inhibitor, pravibismane, in patients with moderate to severe infected diabetic foot ulcers...
A new dawn in diabetic foot care: evidence-based treatments for ulceration
Michael Edmonds, a pioneer in the treatment of the diabetic foot, has underlined the need for innovation and development in the wound care field....
Thousands of diabetic foot ulcer patients could benefit from topical oxygen...
An Expert Panel report published in The Diabetic Foot Journal has recommended a new treatment algorithm for topical oxygen therapy in patients with diabetic foot...
Urgo Medical announces NICE recommendation of UrgoStart for diabetic and venous...
The UK's National Institute of Health and Care Excellence (NICE) has published new guidance recommending UrgoStart wound dressings (Urgo Medical) for treatment of diabetic...
